707(3) an explanation of the firm’s intended split of covered transactions between SA-CVA and BA-CVA, including netting sets, in accordance with 5.3(2).
731(1) as the expectation of future losses resulting from default of the counterparty under the assumption that the firm is free from the default risk;
740(3) by ensuring that for transactions with a significant level of dependence between the exposure and the counterparty’s credit quality, the dependence is taken into account across at least one of the inputs in (2).
748(1) a firm must estimate the term structure of market-implied probability of default using credit spreads of the counterparty where these are observable in the market;
750(2) where credit spreads of the counterparty are not observable in the market, a firm must estimate market-implied probability of default from proxy spreads:
751(a) by estimating the credit spread curve of the counterparty from observable credit spreads using a methodology that discriminates on at least the following three variables:
758(b) by estimating the credit spread curve of the counterparty from the credit spread observed in the market of a single reference name, and must be able to justify the appropriateness of each use of a single reference name to the PRA; or
760(c) using its own assessment of credit risk where no appropriate credit spreads are observable. Where historical probabilities of default are used as part of this assessment, the firm must not base the resulting spread on historical probability of default only.
768(1) unless 5.8(3) applies, the market-consensus expected loss given default value used by the firm must be the same as the one used to calculate the risk-neutral probability of default from credit spreads;
772(3) by way of derogation from (1), if the seniority of the transactions with the counterparty differs from the seniority of senior unsecured bonds that is implied by the value of expected loss given default, the firm must reflect this difference in seniority by adjusting the value of expected loss given default.
781(a) produce the simulated paths of discounted future exposure by pricing all derivative transactions with the counterparty along simulated paths of relevant market risk factors and discounting the prices to the date of calculation using risk-free interest rates along the path; and
783(b) simulate all market risk factors material for the transactions with a counterparty as stochastic processes for an appropriate number of paths defined on an appropriate set of future time points extending to the maturity of the longest transaction.
790(c) the firm has conducted sufficient legal review to verify the condition in point (b) of 5.9(2) and undertakes such further review as necessary to ensure continuing enforceability.
792(3) a firm must, for exposures to counterparties subject to a margin agreement, ensure that:
793(a) the simulated paths of discounted future exposure capture the effects of margining collateral that is recognised as risk mitigation along each exposure path;
795(b) its exposure model appropriately captures all the relevant contractual features including whether unilateral or bilateral, the frequency of margin calls, the type of collateral, margin thresholds, independent amounts, initial margins and minimum transfer amounts; and
797(c) its exposure model assumes a margin period of risk which cannot be less than:
798(i) 4+N business days for securities financing transactions unless the margin agreement has daily or intra-daily exchange of margin, where the margin period of risk is 5 business days; or